Zeriscope, Inc was awarded a Phase I SBIR Grant from National Institute of Mental Health to develop and test a wearable platform that will allow therapists to virtually accompany PTSD patients during the all-important part of therapy known as “In Vivo Exposure”. This new technology system is expected to increase patients’ willingness to attempt in vivo exercises and to enhance their ability to stay in the situations long enough to obtain therapeutic benefit.
